Endovascular therapy versus best medical management in distal medium middle cerebral artery acute ischaemic stroke: a multinational multicentre propensity score-matched study.

IF 8.7 1区 医学 Q1 CLINICAL NEUROLOGY Journal of Neurology, Neurosurgery, and Psychiatry Pub Date : 2024-07-23 DOI:10.1136/jnnp-2024-333669
Hamza Adel Salim, Vivek Yedavalli, Basel Musmar, Nimer Adeeb, Kareem E L Naamani, Nils Henninger, Sri Hari Sundararajan, Anna Luisa Kühn, Jane Khalife, Sherief Ghozy, Luca Scarcia, Benjamin Yong Qiang Tan, Jeremy J Heit, Robert W Regenhardt, Nicole M Cancelliere, Joshua D Bernstock, Aymeric Rouchaud, Jens Fiehler, Muhammed Amir Essibayi, Sunil A Sheth, Ajit S Puri, Xavier Barreau, Marco Colasurdo, Leonardo Renieri, Christian Dyzmann, Thomas Marotta, Julian Spears, Askan Mowla, Pascal Jabbour, João Pedro Filipe, Arundhati Biswas, Pablo Harker, Frédéric Clarençon, Răzvan Alexandru Radu, James E Siegler, Thanh N Nguyen, Ricardo Varela, Takahiro Ota, Nestor Gonzalez, Markus A Moehlenbruch, David Altschul, Benjamin Gory, Vincent Costalat, Christian Paul Stracke, Mohammad Ali Aziz-Sultan, Constantin Hecker, Hamza Shaikh, David S Liebeskind, Amanda Baker, Alessandro Pedicelli, Andrea Alexandre, Tobias D Faizy, Illario Tancredi, Erwah Kalsoum, Boris Lubicz, Aman B Patel, Vitor Mendes Pereira, Adrien Guenego, Adam A Dmytriw
{"title":"Endovascular therapy versus best medical management in distal medium middle cerebral artery acute ischaemic stroke: a multinational multicentre propensity score-matched study.","authors":"Hamza Adel Salim, Vivek Yedavalli, Basel Musmar, Nimer Adeeb, Kareem E L Naamani, Nils Henninger, Sri Hari Sundararajan, Anna Luisa Kühn, Jane Khalife, Sherief Ghozy, Luca Scarcia, Benjamin Yong Qiang Tan, Jeremy J Heit, Robert W Regenhardt, Nicole M Cancelliere, Joshua D Bernstock, Aymeric Rouchaud, Jens Fiehler, Muhammed Amir Essibayi, Sunil A Sheth, Ajit S Puri, Xavier Barreau, Marco Colasurdo, Leonardo Renieri, Christian Dyzmann, Thomas Marotta, Julian Spears, Askan Mowla, Pascal Jabbour, João Pedro Filipe, Arundhati Biswas, Pablo Harker, Frédéric Clarençon, Răzvan Alexandru Radu, James E Siegler, Thanh N Nguyen, Ricardo Varela, Takahiro Ota, Nestor Gonzalez, Markus A Moehlenbruch, David Altschul, Benjamin Gory, Vincent Costalat, Christian Paul Stracke, Mohammad Ali Aziz-Sultan, Constantin Hecker, Hamza Shaikh, David S Liebeskind, Amanda Baker, Alessandro Pedicelli, Andrea Alexandre, Tobias D Faizy, Illario Tancredi, Erwah Kalsoum, Boris Lubicz, Aman B Patel, Vitor Mendes Pereira, Adrien Guenego, Adam A Dmytriw","doi":"10.1136/jnnp-2024-333669","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The efficacy of endovascular treatment (EVT) in acute ischaemic stroke due to distal medium vessel occlusion (DMVO) remains uncertain. Our study aimed to evaluate the safety and efficacy of EVT compared with the best medical management (BMM) in DMVO.</p><p><strong>Methods: </strong>In this prospectively collected, retrospectively reviewed, multicentre cohort study, we analysed data from the Multicentre Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy registry. Patients with acute ischaemic stroke due to DMVO in the M2, M3 and M4 segments who underwent EVT or received BMM were included. Primary outcome measures comprised 10 co-primary endpoints, including functional independence (mRS 0-2), excellent outcome (mRS 0-1), mortality (mRS 6) and haemorrhagic complications. Propensity score matching was employed to balance the cohorts.</p><p><strong>Results: </strong>Among 2125 patients included in the primary analysis, 1713 received EVT and 412 received BMM. After propensity score matching, each group comprised 391 patients. At 90 days, no significant difference was observed in achieving mRS 0-2 between EVT and BMM (adjusted OR 1.00, 95% CI 0.67 to 1.50, p>0.99). However, EVT was associated with higher rates of symptomatic intracerebral haemorrhage (8.4% vs 3.0%, adjusted OR 3.56, 95% CI 1.69 to 7.48, p<0.001) and any intracranial haemorrhage (37% vs 19%, adjusted OR 2.61, 95% CI 1.81 to 3.78, p<0.001). Mortality rates were similar between groups (13% in both, adjusted OR 1.48, 95% CI 0.87 to 2.51, p=0.15).</p><p><strong>Conclusion: </strong>Our findings suggest that while EVT does not significantly improve functional outcomes compared with BMM in DMVO, it is associated with higher risks of haemorrhagic complications. These results support a cautious approach to the use of EVT in DMVO and highlight the need for further prospective randomised trials to refine treatment strategies.</p>","PeriodicalId":16418,"journal":{"name":"Journal of Neurology, Neurosurgery, and Psychiatry","volume":null,"pages":null},"PeriodicalIF":8.7000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology, Neurosurgery, and Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jnnp-2024-333669","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The efficacy of endovascular treatment (EVT) in acute ischaemic stroke due to distal medium vessel occlusion (DMVO) remains uncertain. Our study aimed to evaluate the safety and efficacy of EVT compared with the best medical management (BMM) in DMVO.

Methods: In this prospectively collected, retrospectively reviewed, multicentre cohort study, we analysed data from the Multicentre Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy registry. Patients with acute ischaemic stroke due to DMVO in the M2, M3 and M4 segments who underwent EVT or received BMM were included. Primary outcome measures comprised 10 co-primary endpoints, including functional independence (mRS 0-2), excellent outcome (mRS 0-1), mortality (mRS 6) and haemorrhagic complications. Propensity score matching was employed to balance the cohorts.

Results: Among 2125 patients included in the primary analysis, 1713 received EVT and 412 received BMM. After propensity score matching, each group comprised 391 patients. At 90 days, no significant difference was observed in achieving mRS 0-2 between EVT and BMM (adjusted OR 1.00, 95% CI 0.67 to 1.50, p>0.99). However, EVT was associated with higher rates of symptomatic intracerebral haemorrhage (8.4% vs 3.0%, adjusted OR 3.56, 95% CI 1.69 to 7.48, p<0.001) and any intracranial haemorrhage (37% vs 19%, adjusted OR 2.61, 95% CI 1.81 to 3.78, p<0.001). Mortality rates were similar between groups (13% in both, adjusted OR 1.48, 95% CI 0.87 to 2.51, p=0.15).

Conclusion: Our findings suggest that while EVT does not significantly improve functional outcomes compared with BMM in DMVO, it is associated with higher risks of haemorrhagic complications. These results support a cautious approach to the use of EVT in DMVO and highlight the need for further prospective randomised trials to refine treatment strategies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
远端大脑中动脉急性缺血性卒中的血管内治疗与最佳内科治疗:一项多国多中心倾向评分匹配研究。
背景:血管内治疗(EVT)对远端中血管闭塞(DMVO)引起的急性缺血性卒中的疗效仍不确定。我们的研究旨在评估 EVT 与最佳医疗管理(BMM)相比在 DMVO 中的安全性和有效性:在这项前瞻性收集、回顾性审查的多中心队列研究中,我们分析了来自 "原发性远端中血管闭塞多中心分析:机械取栓术的效果 "登记处的数据。研究纳入了因 M2、M3 和 M4 段 DMVO 而导致急性缺血性中风并接受了 EVT 或 BMM 的患者。主要结局指标包括 10 个共同主要终点,包括功能独立性(mRS 0-2)、良好结局(mRS 0-1)、死亡率(mRS 6)和出血并发症。研究采用倾向评分匹配法来平衡队列:在纳入主要分析的 2125 名患者中,1713 人接受了 EVT,412 人接受了 BMM。经过倾向评分匹配后,每组各有 391 名患者。90 天后,EVT 和 BMM 在达到 mRS 0-2 方面无明显差异(调整 OR 1.00,95% CI 0.67 至 1.50,p>0.99)。然而,EVT与较高的无症状脑出血发生率相关(8.4% vs 3.0%,调整后OR 3.56,95% CI 1.69 to 7.48,p结论:我们的研究结果表明,与 BMM 相比,EVT 并不能显著改善 DMVO 的功能预后,但它与较高的出血并发症风险相关。这些结果支持在 DMVO 中谨慎使用 EVT,并强调需要进一步开展前瞻性随机试验来完善治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.70
自引率
1.80%
发文量
888
审稿时长
6 months
期刊介绍: The Journal of Neurology, Neurosurgery & Psychiatry (JNNP) aspires to publish groundbreaking and cutting-edge research worldwide. Covering the entire spectrum of neurological sciences, the journal focuses on common disorders like stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage, and neuropsychiatry, while also addressing complex challenges such as ALS. With early online publication, regular podcasts, and an extensive archive collection boasting the longest half-life in clinical neuroscience journals, JNNP aims to be a trailblazer in the field.
期刊最新文献
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks. Response to: 'Cortical Inexcitability in ALS: Correlating a Clinical Phenotype'. MYH7-related myopathies: clinical, myopathological and genotypic spectrum in a multicentre French cohort. Huntington's disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing exploration. Exercise as medicine in Parkinson's disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1